We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
FHB
276
First Hawaiian Bank
Hawaii
$434K +$112K +816 +36%
RFC
277
Regions Financial Corp
Alabama
$432K -$15.3K -111 -4%
BIM
278
Bridgecreek Investment Management
Oklahoma
$425K – – –
PGCM
279
Prescott Group Capital Management
Oklahoma
$425K – – –
MC
280
Machina Capital
France
$425K +$367K +2,665 +798%
TC
281
TradeLink Capital
Illinois
$425K +$413K +3,000 New
Balyasny Asset Management
282
Balyasny Asset Management
Illinois
$423K -$2.27M -16,502 -85%
SO
283
STRS Ohio
Ohio
$416K +$75K +545 +23%
Acadian Asset Management
284
Acadian Asset Management
Massachusetts
$401K -$82.2K -597 -17%
VCM
285
Virtue Capital Management
Tennessee
$400K +$155K +1,126 +66%
Cambridge Investment Research Advisors
286
Cambridge Investment Research Advisors
Iowa
$398K -$5.92K -43 -2%
COI
287
Connable Office Inc
Michigan
$397K – – –
KPCM
288
Kings Point Capital Management
New York
$396K -$9.5K -69 -2%
PAG
289
Private Advisor Group
New Jersey
$393K +$381K +2,770 New
QI
290
QS Investors
New York
$383K – – –
HNB
291
Huntington National Bank
Ohio
$380K -$37.9K -275 -9%
PAS
292
Park Avenue Securities
New York
$379K +$368K +2,671 New
CIBC Asset Management
293
CIBC Asset Management
Ontario, Canada
$374K – – –
NA
294
NewEdge Advisors
Louisiana
$372K +$8.81K +64 +3%
MA
295
Montag & Associates
Georgia
$369K – – –
PHK
296
Point72 Hong Kong
Hong Kong
$368K +$72.7K +528 +26%
PG
297
Pendal Group
Australia
$367K -$28.2K -205 -7%
BCM
298
Brookstone Capital Management
Illinois
$364K -$152K -1,106 -30%
AA
299
ALPS Advisors
Colorado
$361K +$351K +2,547 New
MWM
300
Mission Wealth Management
California
$360K -$17.9K -130 -5%
10 11
12
13 14

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.